ask="1.55"
ask_size="1700"
average_daily_volume="792939"
bid="1.15"
bid_size="300"
book_value="1.37"
change="-0.05"
change_from_200_day_moving_average="-1.58"
change_from_50_day_moving_average="-0.84"
change_from_52_week_high="-7.65"
change_From_52_week_low="0.20"
change_in_percent="-3.85%"
close="1.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.31"
ebitda="-61.52M"
eps_estimate_current_year="-1.49"
eps_estimate_next_quarter="-0.37"
eps_estimate_next_year="-1.35"
ex_dividend_date="N/A"
float_shares="36032000"
high="1.35"
high_52_weeks="8.90"
last_trade_date="2/9/2017"
last_trade_price="1.25"
last_trade_size="8394"
last_trade_time="4:00pm"
low="1.15"
low_52_weeks="1.05"
market_capitalization="66.15M"
moving_average_200_day="2.83"
moving_average_50_day="2.09"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="7.00"
open="1.30"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-55.87%"
percent_change_from_50_day_moving_average="-40.30%"
percent_change_from_52_week_high="-85.96%"
percent_change_from_52_week_low="+19.05%"
previous_close="1.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.95"
price_per_sales="5.72"
revenue="12.04M"
shares_outstanding="52923000"
short_ratio="4.53"
stock_exchange="NGM"
symbol="RGLS"
volume="1028448"
weeks_range_52="1.05 - 8.90"
